BackgroundAlthough the postbronchodilator FEV1/FVC is the gold standard for diagnosing COPD, it is not easily obtainable due to various reasons. This study aims to investigate whether FEV1/FEV6 may serve as an easily accessible surrogate for FEV1/FVC in detecting airway obstruction and COPD.MethodsEligible articles were screened from PubMed, Web of Science and Scopus. The Quality Assessment of Diagnostic Accuracy Studies-2 was applied for quality assessment. The pooled sensitivity, specificity, and area under the curve (AUC) of the summary receiver operating curve were calculated to evaluate the diagnostic performance of FEV1/FEV6 in detecting airway obstruction and COPD and to determine the optimal cutoff value. Sensitivity analyses, subgroup analyses and meta-regression were performed to explore the source of heterogeneity.ResultsWith 28 eligible articles and 65,744 subjects, the FEV1/FEV6 ratio showed good diagnostic performance in detecting both airway obstruction (sensitivity: 0.87, specificity: 0.94, AUC 0.95) and COPD (sensitivity: 0.83, specificity: 0.88, AUC 0.91). Further analyses of the optimal cutoff value suggested that an FEV1/FEV61/FEV61/FEV6 may serve as an easily accessible alternative in detecting airway obstruction and COPD. However, application of FEV1/FEV6 may also be constrained by availability and affordability of devices. Further studies are required to determine the best-suited population for FEV1/FEV6 application.
Du et al. (2026) studied this question.